Cytomegalovirus (CMV) & HIV/AIDS
The Basics
- Cytomegalovirus (CMV) (July 8, 2009)
To read PDF, click here
From AIDS InfoNet
- Cytomegalovirus (CMV) (October 2007)
To read PDF, click here
From Project Inform
- You Can Prevent CMV (June 21, 2007)
[Archived Article]
A guide for people with HIV infection.
From U.S. Centers for Disease Control and Prevention
- Cytomegalovirus (CMV) (August 15, 2006)
From AIDS Treatment Data Network
- Cytomegalovirus and HIV (May 2006)
A clinical overview from an online textbook of HIV disease from the University of California San Francisco and San Francisco General Hospital.
From HIV InSite
- What is CMV? (June 10, 2003)
[Archived Article]
To read PDF, click here
In STEP Ezine, from Seattle Treatment Education Project
- Patient/Doctor Q&A: CMV, Cervical Cancer, MRSA and Low Platelets (September 2002)
[Archived Article]
To read PDF, click here
In HIV Treatment ALERTS!, from The Center for AIDS
- Save Your Sight: Eye Disease and HIV (December 2001/January 2002)
[Archived Article]
In Positive Living, from AIDS Project Los Angeles
- Eye Diagram (May 1998)
[Archived Article]
From U.S. National Institutes of Health
- Eye Problems (Summer 1997)
[Archived Article]
In Women Alive Newsletter, from Women Alive
- CMV Background (April/May 1997)
[Archived Article]
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Cidofovir Reaches Drugstores (August 1996)
[Archived Article]
In GMHC Treatment Issues, from Gay Men's Health Crisis
- CMV Retinitis and Treatment: CME Course on World Wide Web (July 5, 1996)
[Archived Article]
In AIDS Treatment News, from AIDS Treatment News
- How to Help Yourself: AIDS-Related CMV (January 1994)
[Archived Article]
From U.S. National Institute of Allergy and Infectious Diseases
- AIDS, HIV, and the Eye
[Archived Article]
From American Academy of Ophthalmology
- The Amsler Grid and Other Self-Tests for CMV Reinitis
[Archived Article]
From AIDS Research Information Center
Prevention
Treatment
- Cidofovir (Vistide, HPMPC) (August 15, 2006)
From AIDS Treatment Data Network
- Ganciclovir Implants (Vitrasert) (August 15, 2006)
From AIDS Treatment Data Network
- Oral Ganciclovir (Cytovene) (August 15, 2006)
From AIDS Treatment Data Network
- Cytomegalovirus Disease (December 17, 2004)
A chapter from "Treating Opportunistic Infections Among HIV-Infected Adults and Adolescents" guidelines.
To read PDF, click here
In Morbidity and Mortality Weekly Report, from U.S. Centers for Disease Control and Prevention
- An Overview of Ganciclovir (Cytovene, Vitrasert) (September 28, 2004)
To read PDF, click here
From U.S. National Institutes of Health
- Valganciclovir: A New Treatment for Cytomegalovirus Retinitis (Winter 2002/2003)
[Archived Article]
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- 2002 Safety Alert: Cytovene IV (Ganciclovir Sodium for Injection) (February 13, 2002)
[Archived Article]
From U.S. Food and Drug Administration
- Valganciclovir Recommended for Approval (April 2001)
[Archived Article]
In What's New, from Project Inform
- Advances in CMV Management: Fomivirsen (Vitravene®) Approved (December 1998)
[Archived Article]
In Project Inform Perspective, from Project Inform
- New CMV Retinitis Drug Approved (October 1998)
[Archived Article]
In Body Positive, from Body Positive
- Fomivirsen Approved for CMV Retinitis: First Antisense Drug (September 4, 1998)
[Archived Article]
From AIDS Treatment News
- Approval Letter for the Use of Vitravene Injection for the Local Treatment of Cytomegalovirus (CMV) Retinitis (August 28, 1998)
[Archived Article]
From U.S. Food and Drug Administration
- Better Treatment for CMV Retinitis: An Update (August 1998)
[Archived Article]
In HIV Newsline, from San Francisco General Hospital
- Improved Treatment of CMV Retinitis (February 1998)
[Archived Article]
In HIV Newsline, from San Francisco General Hospital
- CMV Viremia: A Look at the Other Viral Load (December 1997/January 1998)
[Archived Article]
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Improved Ganciclovir Regimens (December 1997/January 1998)
[Archived Article]
In GMHC Treatment Issues, from Gay Men's Health Crisis
- The Vitrasert Ganciclovir Implant's Place in the CMV Treatment Line Up (April/May 1997)
[Archived Article]
In GMHC Treatment Issues, from Gay Men's Health Crisis
- The State of the Art: Treatment of CMV Disease (Spring 1997)
[Archived Article]
A comprehensive report.
In Direct Information on Research and Treatment Newsletter, from ARIC
- Cidofovir Warning (October 1996)
[Archived Article]
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Cidofovir Recommended for Approval for CMV Retinitis (April 5, 1996)
[Archived Article]
In AIDS Treatment News, from AIDS Treatment News
- New Developments in the Management of CMV Infections (April 1996)
[Archived Article]
In HIV Newsline, from San Francisco General Hospital
- CMV: The Other Virus (March 1996)
[Archived Article]
In GMHC Treatment Issues, from Gay Men's Health Crisis
- New Drug Recommended for Treament of CMV Retinitis (Spring 1996)
[Archived Article]
In STEP Perspective, from Seattle Treatment Education Project
- And Also, "Adefovir Dipovixil" (February 1996)
[Archived Article]
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Finding a Place for Cidofovir (January 1996)
[Archived Article]
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Oral Ganciclovir (Winter 1995)
[Archived Article]
In STEP Perspective, from Seattle Treatment Education Project
- Ganciclovir for CMV Retinitis (Summer 1995)
[Archived Article]
In STEP Perspective, from Seattle Treatment Education Project
- New Treatments, New Hope in Avoiding Blindness (June 1995)
[Archived Article]
From amfAR, The Foundation for AIDS Research
Personal Accounts
Research
- Experimental Vaccine Shows Promise in Preventing Cytomegalovirus Infection (March 19, 2009)
From U.S. National Institute of Allergy and Infectious Diseases
- Cytomegalovirus Viremia, Mortality, and End-Organ Disease Among Patients With AIDS Receiving Potent Antiretroviral Therapies (April 15, 2005)
In Journal of Acquired Immune Deficiency Syndromes
- CMV Levels May Predict HIV Disease Progression (October 2004)
Quick recap of a study in The Lancet.
In HIV Treatment ALERTS!, from The Center for AIDS
- HAART Good for Vision and Quality of Life, Studies Find (June 18, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- A Synergistic Effect of HIV and CMV Infection/Reactivation on Response to HAART and Plasma CD8+/CD38+ But Not CD4+ Cell Populations in Patients With Primary HIV Infection (July 10, 2002)
[Archived Article]
In The XIV International AIDS Conference, from The Body PRO
- Oral Valganciclovir as Effective as IV Ganciclovir in Treating CMV Retinitis in AIDS Patients (April 12, 2002)
[Archived Article]
Results of a recent Emory University study.
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Discontinuation of Maintenance Therapy for Cytomegalovirus Retinitis in HIV-Infected Patients Who Have Responded to Highly Active Antiretroviral Therapy (December 18, 2001)
[Archived Article]
In 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2001), from The Body PRO
- Needleless Retinitis Therapy with FDA Approval of Oral CMV Drug (April 2001)
[Archived Article]
In TAGline, from Treatment Action Group
- Advances in Treating CMV (August 2000)
[Archived Article]
In Project Inform Perspective, from Project Inform
- Long-Term Effects of HAART on Morbidity and Mortality in HIV-1-Infected Patients at Risk for CMV Disease (January 31, 2000)
[Archived Article]
In The 7th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Multicenter Evaluation of CMV Reactivation in HIV-infected Women at Potential Risk for CMV Disease (January 31, 2000)
[Archived Article]
In The 7th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Anti-HIV Treatment Improves Immune System and Fights Sight-Threatening Eye Infection (November 2, 1999)
[Archived Article]
From U.S. National Institutes of Health
- Update: Treatment of CMV Retinitis (October 1999)
[Archived Article]
In HIV Newsline, from San Francisco General Hospital
- A New Acronym, a New Threat: IRU (September 1999)
[Archived Article]
In Project Inform Perspective, from Project Inform
- Secondary Prophylaxis for CMV Retinitis (August 1999)
[Archived Article]
In HIV Newsline, from San Francisco General Hospital
- HIV-Related Clinical Updates: CMV/Cytomegalovirus Disease (May 2, 1998)
[Archived Article]
In The 8th Clinical Care Options for HIV Symposium, from The Body PRO
- Impact of Highly Active Antiretroviral Therapy on Opportunistic Infections (3 abstracts) (September 28-October 1, 1997)
[Archived Article]
In The 37th Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy, from The Body PRO
- CMV Trials Struggle to Enroll (September 1997)
[Archived Article]
In GMHC Treatment Issues, from Gay Men's Health Crisis
- CMV: Pathogenesis, Viral Load and Prophylaxis Treatment Strategies (June 1997)
[Archived Article]
In The 7th Annual Clinical Care Options for HIV Symposium, from The Body PRO
- CMV Retinitis, Newly Diagnosed: RS-79070 Trial (May 1, 1997)
[Archived Article]
From AIDS Treatment News
- CMV, RS-79070: Community Concern As Major Drug's Development Suspended (May 1, 1997)
[Archived Article]
From AIDS Treatment News
- Combination Drug Therapy for AIDS Found to Control Blinding Eye Infection (May 1997)
[Archived Article]
From U.S. National Institutes of Health
- Ganciclovir Prodrug Development Program Languishes While Roche Determines Market Demand (April/May 1997)
[Archived Article]
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Treatment of CMV Retinitis (March 1997)
[Archived Article]
In Hopkins HIV Report, from Johns Hopkins AIDS Service
- CMV Retinitis Despite High CD4 Lymphocyte Counts (January 1997)
[Archived Article]
In The 4th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Lobucavir (January 1997)
[Archived Article]
In The 4th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- CPCRA v. Syntex (November 1996)
[Archived Article]
Effect of ddI on Ganciclovir may explain disparity between two prophylaxis studies.
From Treatment Action Group
- Cytomegalovirus: Report from the The Third International Conference on Drug Therapy in HIV Infection (November 1996)
[Archived Article]
In Journal of the International Association of Physicians in AIDS Care, from International Association of Physicians in AIDS Care
- Responding to CMV Neurologic Infections (November 1996)
[Archived Article]
In GMHC Treatment Issues, from Gay Men's Health Crisis
- CMV Information: Print, Online, Phone, Video (October 1996)
[Archived Article]
In AIDS Treatment News, from AIDS Treatment News
- CMV Retinitis Study Aborted (September 1996)
[Archived Article]
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Combination of Ganciclovir and Foscarnet Better than Monotherapy for Retinitis (April 1996)
[Archived Article]
In HIV Newsline, from San Francisco General Hospital
- Cytomegalovirus Retinitis: New Approaches (March 1996)
[Archived Article]
In Moore News for Care Providers, from Johns Hopkins AIDS Service
|
|
Advertisement
|
E-Mail
Glossary
Share
